- Home
- PESI vs CMPX Comparison
PESI vs CMPX Comparison
Compare PESI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- CMPX
- Stock Information
- Founded
- PESI 1990
- CMPX 2014
- Country
- PESI United States
- CMPX United States
- Employees
- PESI N/A
- CMPX N/A
- Industry
- PESI Environmental Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- PESI Industrials
- CMPX Health Care
- Exchange
- PESI Nasdaq
- CMPX Nasdaq
- Market Cap
- PESI 153.6M
- CMPX 217.4M
- IPO Year
- PESI 1992
- CMPX N/A
- Fundamental
- Price
- PESI $10.79
- CMPX $1.50
- Analyst Decision
- PESI Strong Buy
- CMPX Strong Buy
- Analyst Count
- PESI 1
- CMPX 2
- Target Price
- PESI $18.00
- CMPX $9.00
- AVG Volume (30 Days)
- PESI 79.9K
- CMPX 381.1K
- Earning Date
- PESI 10-31-2024
- CMPX 11-07-2024
- Dividend Yield
- PESI N/A
- CMPX N/A
- EPS Growth
- PESI N/A
- CMPX N/A
- EPS
- PESI N/A
- CMPX N/A
- Revenue
- PESI $72,199,000.00
- CMPX $850,000.00
- Revenue This Year
- PESI N/A
- CMPX N/A
- Revenue Next Year
- PESI $52.51
- CMPX $950.68
- P/E Ratio
- PESI N/A
- CMPX N/A
- Revenue Growth
- PESI N/A
- CMPX N/A
- 52 Week Low
- PESI $6.51
- CMPX $0.77
- 52 Week High
- PESI $14.17
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- PESI 52.78
- CMPX 60.19
- Support Level
- PESI $9.58
- CMPX $1.42
- Resistance Level
- PESI $10.78
- CMPX $1.65
- Average True Range (ATR)
- PESI 0.57
- CMPX 0.13
- MACD
- PESI 0.00
- CMPX 0.02
- Stochastic Oscillator
- PESI 64.02
- CMPX 51.95
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.